Compare · AKUS vs ZONE
AKUS vs ZONE
Side-by-side comparison of Akouos Inc. (AKUS) and Zone Frontier Inc. (ZONE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AKUS and ZONE operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- ZONE carries a market cap of $26.8M.
- ZONE has hit the wire 8 times in the past 4 weeks while AKUS has been quiet.
- AKUS has more recent analyst coverage (1 ratings vs 0 for ZONE).
- Company
- Akouos Inc.
- Zone Frontier Inc.
- Price
- -
- -
- Market cap
- -
- $26.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- AMEX
- IPO
- 2020
- 2024
- News (4w)
- 0
- 8
- Recent ratings
- 1
- 0
Akouos Inc.
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.
Zone Frontier Inc.
Zone Frontier Inc. (NYSE AMERICAN: ZONE) is helping to build the critical infrastructure that powers the AI economy. Through a growing pipeline of projects, the Company aims to help meet the increasing demand for compute capacity, power, and digital infrastructure required by the world's leading AI companies.
Latest AKUS
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form 15-12G filed by Akouos Inc.
- SEC Form EFFECT filed by Akouos Inc.
- SEC Form 4 filed by Walker Paul Edward (tax withholding)
- SEC Form 4 filed by Sonsini Peter W. (tax withholding)
- SEC Form 4 filed by Sandell Scott D to satisfy withholding tax
- SEC Form 4 filed by Mathers Edward T (tax withholding)
Latest ZONE
- SEC Form NT 10-Q filed by Zone Frontier Inc.
- SEC Form SCHEDULE 13G filed by Zone Frontier Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Zone Frontier Inc.
- SEC Form SCHEDULE 13G filed by Zone Frontier Inc.
- SEC Form SCHEDULE 13G filed by Zone Frontier Inc.
- Zone Frontier Inc. Provides Shareholder Update on Minnesota Execution and Debt Financing Progress, Completed Strategic Transformation, Insider Share Purchases and Texas Project
- SEC Form 8-K filed by CleanCore Solutions Inc.
- Amendment: SEC Form 10-K/A filed by CleanCore Solutions Inc.
- Zone Frontier Inc. Announces 1-for-60 Reverse Stock Split
- Chief Executive Officer Hassen Tyler Lewis bought $55,150 worth of shares (500,000 units at $0.11) (SEC Form 4)